Ajay Vishwakarma

Company: CellBioEngines

Job title: Founder & Chief Executive Officer

Seminars:

Panel Discussion: Ensuring Lasting Therapeutic Responses from Allogeneic Therapy – Is Redosing the Way to Go? 8:30 am

Examine the role of redosing in sustaining therapeutic efficacy and preventing disease relapse in patients receiving allogeneic therapies How do we determine if multiple doses are needed and if so, how do we determine how many? Is it better to use a one and done model or plan for multiple doses? Analyze the impact of treatment…Read more

day: Conference Day Two

Consistency & Control in Cell Phenotypes: Ensuring Reliable Expansion for Scalable Manufacturing 1:00 pm

As allogeneic developers prepare for pivotal scale-up, understanding how to maintain uniformity in cell characteristics becomes crucial. The workshop will explore the latest methodologies, technologies, and best practices for optimizing cell expansion processes. Join this workshop to:  Explore the complexities of achieving consistent cell phenotypes in the context of allogeneic therapies and understand the factors that contribute to variability Learn about…Read more

day: Pre-Conference Workshops - Track B PM